Alerts will be sent to your verified email
Verify Email
AMIORG
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Ami Organics Limited specializes in advanced pharmaceutical intermediates and key starting material for agrochemical and fine chemicals. They are a major manufacturer for key APIs like Dolutegravir and Rivaroxaban.
Acutaas Chemicals major competitors are Supriya Lifescience, Aether Industries, Granules India, Alivus Life Sciences, Aarti Pharmalabs, Neuland Laboratories, Shilpa Medicare.
Market Cap of Acutaas Chemicals is ₹14,113 Crs.
While the median market cap of its peers are ₹9,989 Crs.
Acutaas Chemicals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul Oct | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||||||
| Investor Presentation | May Jul Oct | Mar May Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Sep Dec | |||||||||||||
| Conference Call | Mar Jun Sep | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
